Stallergenes Greer, a biopharmaceutical company specialising in the research, diagnosis and treatment of respiratory allergies, is pleased to announce its strategic direction for the Stallergenes Greer Foundation. The Stallergenes Greer Foundation, under the aegis of the Fondation de France, aims…
Mawi DNA Technologies (Mawi DNA), ein Biotechnologieunternehmen, das sich auf die Entwicklung und das Design innovativer Technologien für die Bioprobenentnahme konzentriert, gibt bekannt, dass die U.S. Food and Drug Administration (FDA) die 510(k)-Zulassung für die “iSWAB-Respiratory Tract Sample Collection Media-Extraction Less™”…
Reperio Health, the only provider of at-home, comprehensive health screenings with instant results, today announced the appointment of Naomi Levinthal as Chief Growth Officer. In her new role, Levinthal will lead Reperio’s commercial operations and strategy as the company continues…
R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, today announced a new solution designed to streamline the product recall communication process for medical device companies. Seamlessly integrating RRD’s highly refined…
A pioneering medical imaging software and devices company, today announced that Exo Works™, the company’s point-of-care ultrasound workflow solution, has earned Certified status for information security by HITRUST and has successfully completed the Service Organization Control (SOC 2) Type II certification. These achievements provide additional…
EnChroma – creators of glasses for color blindness – and the University of North Carolina at Chapel Hill’s Department of Health Sciencestoday announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient…
Veristat, une organisation mondiale de recherche clinique (CRO) à l’esprit scientifique, a félicité aujourd’hui HIPRA pour l’autorisation de mise sur le marché par l’Agence européenne des médicaments (EMA) et la Commission européenne de BIMERVAX®, un vaccin bivalent avec adjuvant basé sur les…
a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The Lattus™ Lateral Access System and the Fathom™ Pedicle-Based Retractor System expand the Company’s offering of access…
A leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced that it has named Scott Huennekens executive chairman of its board of directors. “Having Scott join us as executive chairman at this…
“Myrtelle” or the “Company”, a clinical stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA), the healthcare regulatory body of the United Kingdom (UK), granted Innovative…
Juno Pharmaceuticals Canada (“Juno”), a Canadian specialty pharmaceutical company, announced its partnership with U.K. based developer, manufacturer and global supplier of novel, Rx, oral liquid medicines, Rosemont Pharmaceuticals (“Rosemont”), as its exclusive Canadian distributor. Through this partnership, several of Rosemont’s…
Juno Pharmaceuticals Canada (« Juno »), une société pharmaceutique canadienne spécialisée, annonce son partenariat avec Rosemont Pharmaceuticals (« Rosemont ») pour devenir son distributeur canadien exclusif. Rosemont est une entreprise établie au Royaume-Uni qui développe, fabrique et fournit des médicaments…